Document Detail


Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
MedLine Citation:
PMID:  23338774     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Surgery, radiation and chemotherapy are the standard of care for GBM patients, however, the impact of extent of resection (EOR) and radiotherapy (RT) on patient survival across age groups has not been established. Therefore, we present the current largest study on EOR and RT in GBM over the past three decades. Using the population based Surveillance, Epidemiology and End Results (SEER) registry, we identified a total of 21,783 GBM patients (1973‑2007). Survival analysis based on EOR and RT was performed by means of factor analysis, Kaplan‑Meier survival and Cox proportional hazard's ratio. Age, RT and EOR were highly prognostic (p<0.00001). Combined gross total resection (GTR) and RT showed the longest median survival (11 months) compared to subtotal resection (STR) and RT (9 months). Survival times after monotherapy with RT, GTR and STR were 5, 3 and 2 months, respectively. Patients without therapy showed a median survival of 1 month. RT and GTR demonstrated highest median survival. Interestingly, survival advantage of GTR versus STR amounted to only 1-2 months. Monotherapy (GTR, STR or RT) showed a significantly lower survival rate compared to combination therapies. RT alone yielded significantly better survival compared to any resective approach. Relative to overall age-specific median survival, elderly patients still reasonably benefit from RT alone. However, across all age groups multimodality treatment with surgery and RT continues to provide the largest survival benefit compared to either treatment alone and, thus, should be pursued whenever feasible.
Authors:
Pascal O Zinn; Rivka R Colen; Ekkehard M Kasper; Jan-Karl Burkhardt
Related Documents :
23292874 - Retrospective analysis of prognosticators in patients with relapsed hodgkin's lymphoma ...
11147224 - Studies of minimal residual disease in acute lymphocytic leukemia.
22927484 - Developing and validating continuous genomic signatures in randomized clinical trials f...
8912594 - Dapsone in prevention of recurrent neutrophilic eccrine hidradenitis.
24688774 - Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiatio...
4027864 - Patterns of relapse in locally advanced head and neck cancer patients who achieved comp...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-15
Journal Detail:
Title:  International journal of oncology     Volume:  -     ISSN:  1791-2423     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acupuncture for cancer pain and related symptoms.
Next Document:  Behavioral Interventions and Counseling to Prevent Child Abuse and Neglect: A Systematic Review to U...